| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Derazantinib (ARQ087) |
|---|
| Description | Derazantinib is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. It binds to and potently inhibits the activity of FGFR subtypes 1, 2 and 3. This may result in the inhibition of FGFR-mediated signal transduction pathways, tumor cell proliferation, tumor angiogenesis and tumor cell death in FGFR-overexpressing tumor cells. MW: 468.58. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (6R)-6-(2-fluorophenyl)-N-(3-{2-[(2-methoxyethyl)amino]ethyl}phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine; ARQ-087 |
|---|
| Gene, Accession, CAS # | CAS: 1234356-69-4 |
|---|
| Catalog # | B2222-5 |
|---|
| Price | |
|---|
| Order / More Info | Derazantinib (ARQ087) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|